Overcoming the barriers to better evidence generation from clinical trials
Clinical evidence generation from and for representative populations can be improved through increased research access and ease of trial participation. To improve access and participation, a modern trial infrastructure is needed that broadens research into more routine practice. This commentary high...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2024
|
| _version_ | 1817930728715845632 |
|---|---|
| author | Kehoe, L Locke, T McClellan, M Hernandez, A Landray, M Okun, S |
| author_facet | Kehoe, L Locke, T McClellan, M Hernandez, A Landray, M Okun, S |
| author_sort | Kehoe, L |
| collection | OXFORD |
| description | Clinical evidence generation from and for representative populations can be improved through
increased research access and ease of trial participation. To improve access and participation, a
modern trial infrastructure is needed that broadens research into more routine practice. This
commentary highlights current barriers, areas of advancement, and actions needed to enable
continued transformation toward a modern trial infrastructure for an improved evidence
generation system. The focus of this commentary is on the development of medical products
(e.g., drugs, devices, biologics) and infrastructure issues within the United States, with the aim to
have broader, multi-national applicability. |
| first_indexed | 2024-09-25T04:34:19Z |
| format | Journal article |
| id | oxford-uuid:f8b3b980-b277-44c3-be76-8050b55730d0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-12-09T03:10:44Z |
| publishDate | 2024 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:f8b3b980-b277-44c3-be76-8050b55730d02024-10-04T11:04:43ZOvercoming the barriers to better evidence generation from clinical trialsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f8b3b980-b277-44c3-be76-8050b55730d0EnglishSymplectic ElementsBioMed Central2024Kehoe, LLocke, TMcClellan, MHernandez, ALandray, MOkun, SClinical evidence generation from and for representative populations can be improved through increased research access and ease of trial participation. To improve access and participation, a modern trial infrastructure is needed that broadens research into more routine practice. This commentary highlights current barriers, areas of advancement, and actions needed to enable continued transformation toward a modern trial infrastructure for an improved evidence generation system. The focus of this commentary is on the development of medical products (e.g., drugs, devices, biologics) and infrastructure issues within the United States, with the aim to have broader, multi-national applicability. |
| spellingShingle | Kehoe, L Locke, T McClellan, M Hernandez, A Landray, M Okun, S Overcoming the barriers to better evidence generation from clinical trials |
| title | Overcoming the barriers to better evidence generation from clinical trials |
| title_full | Overcoming the barriers to better evidence generation from clinical trials |
| title_fullStr | Overcoming the barriers to better evidence generation from clinical trials |
| title_full_unstemmed | Overcoming the barriers to better evidence generation from clinical trials |
| title_short | Overcoming the barriers to better evidence generation from clinical trials |
| title_sort | overcoming the barriers to better evidence generation from clinical trials |
| work_keys_str_mv | AT kehoel overcomingthebarrierstobetterevidencegenerationfromclinicaltrials AT locket overcomingthebarrierstobetterevidencegenerationfromclinicaltrials AT mcclellanm overcomingthebarrierstobetterevidencegenerationfromclinicaltrials AT hernandeza overcomingthebarrierstobetterevidencegenerationfromclinicaltrials AT landraym overcomingthebarrierstobetterevidencegenerationfromclinicaltrials AT okuns overcomingthebarrierstobetterevidencegenerationfromclinicaltrials |